Niranjan Sardesai
CIK 1464547 · View on SEC EDGAR ↗
First SEC filing: Jan. 4, 2012 · Latest: Jan. 4, 2012
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 29, 2016 | INO | S | 21,800 | $9.30 | $202,740 | 48,434 Direct | -31.04% | Disposed | -98.9% (price as of 2026-08-20) |
| Sept. 30, 2015 | INO | P | 4,000 | $5.50 | $22,000 | 32,000 Direct | +14.29% | Acquired | -98.1% (price as of 2026-08-20) |
| Aug. 12, 2014 | INO | P | 2,550 | $8.70 | $22,185 | 28,000 Direct | +10.02% | Acquired | -98.8% (price as of 2026-08-20) |
| March 20, 2013 | INO | P | 25,000 | $0.53 | $13,250 | 101,800 Direct | +32.55% | Acquired | -95.0% (price as of 2026-08-20) |
| May 16, 2012 | INO | P | 10,000 | $0.45 | $4,500 | 76,800 Direct | +14.97% | Acquired | -94.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 10, 2018 | INO | Restricted Stock Unit | Common Stock (20,434) | — | — | 20,434 | Disposed |
| March 9, 2018 | INO | Restricted Stock Unit | Common Stock (25,000) | — | — | 25,000 | Disposed |
| March 5, 2018 | INO | Restricted Stock Unit | Common Stock (82,700) | — | — | 82,700 | Acquired |
| March 5, 2018 | INO | Common Stock Option | Common Stock (126,500) | $4.29 | March 5, 2028 | 126,500 | Acquired |
| March 5, 2018 | INO | Restricted Stock Unit | Common Stock (8,333) | — | — | 8,333 | Disposed |
| March 10, 2017 | INO | Restricted Stock Unit | Common Stock (61,300) | — | — | 61,300 | Acquired |
| March 10, 2017 | INO | Common Stock Option | Common Stock (100,000) | $6.68 | March 10, 2027 | 100,000 | Acquired |
| March 9, 2017 | INO | Restricted Stock Unit | Common Stock (25,000) | — | — | 25,000 | Disposed |
| March 5, 2017 | INO | Restricted Stock Unit | Common Stock (8,333) | — | — | 8,333 | Disposed |
| Jan. 4, 2017 | INO | Common Stock Option | Common Stock (3,680) | $6.12 | Jan. 18, 2017 | 3,680 | Disposed |
| Jan. 4, 2017 | INO | Common Stock Option | Common Stock (6,133) | $6.12 | Jan. 5, 2017 | 6,133 | Disposed |
| Aug. 28, 2016 | INO | Common Stock Options | Common Stock (33,116) | $6.12 | Aug. 28, 2016 | 33,116 | Disposed |
| March 9, 2016 | INO | Restricted Stock Unit | Common Stock (75,000) | — | — | 75,000 | Acquired |
| March 9, 2016 | INO | Common Stock Options | Common Stock (67,500) | $7.02 | March 9, 2026 | 67,500 | Acquired |
| March 5, 2016 | INO | Restricted Stock Unit | Common Stock (8,334) | — | — | 8,334 | Disposed |
| March 5, 2015 | INO | Common Stock Options | Common Stock (60,000) | $7.56 | March 5, 2025 | 60,000 | Acquired |
| March 5, 2015 | INO | Restricted Stock Unit | Common Stock (25,000) | — | — | 25,000 | Acquired |
| May 22, 2014 | INO | Common Stock Option | Common Stock (155,000) | $2.20 | May 22, 2024 | 155,000 | Acquired |
| March 23, 2014 | INO | Common Stock Option [F1] | Common Stock (150,000) | $3.23 | March 26, 2024 | 150,000 | Acquired |
| March 14, 2013 | INO | Common Stock Options [F1] | Common Stock (180,000) | $0.54 | March 14, 2023 | 180,000 | Acquired |
| Feb. 23, 2012 | INO | Common Stock Options [F1] | Common Stock (175,000) | $0.60 | Feb. 23, 2022 | 175,000 | Acquired |
| Jan. 3, 2012 | INO | Common Stock Option | Common Stock (50,000) | $0.44 | Jan. 3, 2022 | 50,000 | Acquired |
| Sept. 30, 2009 | INO | Common Stock Options | Common Stock (120,000) | $1.57 | Sept. 30, 2019 | 120,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 15 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 4, 2012 | INO | Common Stock | 66,800 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (132,462) | 132,462 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (24,530) | 24,530 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (14,718) | 14,718 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (73,590) | 73,590 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (29,436) | 29,436 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F1]→ Common Stock (19,624) | 19,624 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F2]→ Common Stock (120,000) | 120,000 | Direct |
| Jan. 4, 2012 | INO | Common Stock Option [F3]→ Common Stock (120,000) | 120,000 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F3]→ Inovio Biomedical Corporation Common Stock (132,462) | 132,462 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F4]→ Inovio Biomedical Corporation Common Stock (24,530) | 24,530 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F5]→ Inovio Biomedical Corporation Common Stock (14,718) | 14,718 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F6]→ Inovio Biomedical Corporation Common Stock (73,590) | 73,590 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F7]→ Inovio Biomedical Corporation Common Stock (29,436) | 29,436 | Direct |
| June 3, 2009 | INO | Inovio Biomedical Corporation Common Stock Option [F1,F2,F8]→ Inovio Biomedical Corporation Common Stock (19,624) | 19,624 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $448,101 | — | $354,783 | — | $171,238 | — | $15,250 | $1,347,984 |
| 2017 | $435,051 | — | $450,078 | — | $148,750 | — | $9,153 | $1,480,618 |
| 2016 | $409,715 | $156,311 | $526,500 | — | — | — | $9,418 | $1,392,782 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.